Walter Matthew R. 4

4 · Medtronic plc · Filed Aug 4, 2025

Form 4

Period: 2025-08-01

SVP, Chief HR Officer

Transactions

Exercise/Conversion
Ordinary Shares
2025-08-01+2,179→ 32,804 total
Exercise/Conversion
Ordinary Shares
2025-08-01$78.00/sh+963$75,114→ 32,736 total
Exercise/Conversion
Performance Share Unit
2025-08-01−2,179→ 0 total
→ Ordinary Shares (2,179 underlying)
Tax Payment
Ordinary Shares
2025-08-01$89.34/sh−879$78,530→ 31,857 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-08-01−963→ 0 total
Exercise: $78.00Exp: 2025-08-03→ Ordinary Shares (963 underlying)
Tax Payment
Ordinary Shares
2025-08-01$89.34/sh−667$59,590→ 32,137 total
Tax Payment
Ordinary Shares
2025-08-01$89.34/sh−364$32,520→ 31,773 total

Footnotes (6)

[F1]Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 1, 2022 and earned dividend equivalents.
[F2]Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 1, 2025.
[F3]Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.
[F4]Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
[F5]The performance share units vested on August 1, 2025.
[F6]These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

Documents

1 file